These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4696262)

  • 41. What is quality of medicines?
    Doogue MP; Thynne TR
    Intern Med J; 2013 Oct; 43(10):1057-8. PubMed ID: 24134167
    [No Abstract]   [Full Text] [Related]  

  • 42. [Production and control in pharmaceutical industry. Testing of samples and release. Organization and practice in middle-sized plants].
    Schlumpf R
    Pharm Acta Helv; 1973; 48(8):471-81. PubMed ID: 4766788
    [No Abstract]   [Full Text] [Related]  

  • 43. [Production and control in pharmaceutical industry. Testing of samples and release. Organization and practice in bigger plants].
    Forster O
    Pharm Acta Helv; 1973; 48(8):455-70. PubMed ID: 4766787
    [No Abstract]   [Full Text] [Related]  

  • 44. [Changes in the norms governing practices for the manufacture of pharmaceutical products: implications for the MERCOSUR].
    Temprano G; Prats S; Bregni C
    Boll Chim Farm; 1998 Nov; 137(10):426-38. PubMed ID: 9880947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Basic of compounding: Repackaging, Part 1.
    Allen LV
    Int J Pharm Compd; 2013; 17(1):54-60. PubMed ID: 23627248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmaceutical controls for drug availability.
    Bethel RF
    Med Serv J Can; 1967 Mar; 23(3):337-45. PubMed ID: 6061040
    [No Abstract]   [Full Text] [Related]  

  • 48. Short communication: a study on the packaging information of essential drug products used at Union and Thana health complex level in Bangladesh.
    Amran S; Ahmed M; Shaheen SM; Morshed SN; Khandakar J; Rahman M; Rahman M; Hossain A
    Pak J Pharm Sci; 2007 Oct; 20(4):327-32. PubMed ID: 17604258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Guidance for temperature-controlled medicinal products: maintaining the quality of temperature-sensitive medicinal products through the transportation environment.
    Parenteral Drug Association
    PDA J Pharm Sci Technol; 2007; 61(2 Suppl TR 39):2-19. PubMed ID: 17953229
    [No Abstract]   [Full Text] [Related]  

  • 50. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microbial content in non-sterile pharmaceuticals. I. Introduction.
    Dan Tidsskr Farm; 1968; 42(1):1-4. PubMed ID: 4968767
    [No Abstract]   [Full Text] [Related]  

  • 52. [Proposals for the legal control of the testing and introduction of drugs based on a comparison of drug laws in other countries].
    Burow W; Lüllmann H
    Schriftenr Geb Off Gesundheitswes; 1971; 31():1-64. PubMed ID: 5153578
    [No Abstract]   [Full Text] [Related]  

  • 53. Master and batch records in parenteral product manufacture.
    Syverson JA
    Bull Parenter Drug Assoc; 1972; 26(5):239-46. PubMed ID: 5083452
    [No Abstract]   [Full Text] [Related]  

  • 54. Feasibility of unit dose packaging of medications for inhalation therapy.
    Talley JR; Magarian RA; Sommers EB
    Am J Hosp Pharm; 1973 Jun; 30(6):526-30. PubMed ID: 4709934
    [No Abstract]   [Full Text] [Related]  

  • 55. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Panel discussion: practical importance of generic equivalence.
    Ann Clin Res; 1974; 6(0):suppl 11:79-88. PubMed ID: 4212521
    [No Abstract]   [Full Text] [Related]  

  • 57. Panel discussion: in process control and inspection for quality assurance. I.
    Shea JJ
    Bull Parenter Drug Assoc; 1968; 22(2):82-7. PubMed ID: 5649570
    [No Abstract]   [Full Text] [Related]  

  • 58. [The trade-mark].
    Kohlstaedt E
    Med Welt; 1969 Oct; 40():2209-11. PubMed ID: 5355668
    [No Abstract]   [Full Text] [Related]  

  • 59. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Production in middle size plants].
    Bucher K
    Pharm Acta Helv; 1973 Feb; 48(2):101-16. PubMed ID: 4706308
    [No Abstract]   [Full Text] [Related]  

  • 60. Development of quality-awareness program for production operators.
    Barr EG
    Bull Parenter Drug Assoc; 1975; 29(6):316-9. PubMed ID: 1203610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.